Ex parte STEPHAN D. CRANE - Page 3




                 Appeal No. 95-3959                                                                                                                     
                 Application 08/051,492                                                                                                                 



                          Claims 1 through 5 stand rejected under 35 U.S.C. § 112, first paragraph, as                                                  
                 being nonenabled, and under 35 U.S.C. § 112, second paragraph, as being indefinite.                                                    
                 In addition, claims 1 through 5 stand rejected under 35 U.S.C. § 103 as unpatentable                                                   
                 over Henningfield.  We reverse the rejections under 35 U.S.C. § 112, first and second                                                  
                 paragraphs, and vacate the rejection under 35 U.S.C. § 103.                                                                            


                                           Rejection Under 35 U.S.C. § 112, First Paragraph                                                             
                          As seen from claim 1 on appeal, the claimed invention is directed to a method                                                 
                 for providing nutrition to a pet which involves the step of administering an enteral                                                   
                 suspension of nutrients by a syringe.  The examiner has determined that the claims on                                                  
                 appeal are nonenabled for two separate reasons.  First, the examiner states at page 32                                                 
                 of the Examiner’s Answer:                                                                                                              
                          As written, the disclosure fails to properly describe the composition of                                                      
                          the nutritional supplement.  More details are provided concerning the                                                         
                          emulsion characteristics of the composition than anything else.                                                               
                 In addition, the examiner has determined at the second page 3 of the Examiner’s                                                        
                 Answer that                                                                                                                            
                          the disclosure is enabling only for claims limited to a method of providing                                                   
                          nutrition wherein the emulsion contains no less than about 10% protein,                                                       

                          2The Examiner’s Answer contains two page 3s.  This citation is to the first page                                              
                 3.                                                                                                                                     
                                                                           3                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007